The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Criteria of drug-induced liver disorders
Abstract
International reporting of adverse drug reactions by pharmaceutical manufacturers to national drug regulatory authorities requires internationally accepted standard definitions of reactions and criteria for assessment of causality. The Council for International Organizations of Medical Sciences (CIOMS) undertook a pilot project to prepare such definitions and criteria, and proposed to use as its model a series of expert consensus meetings organized in France by the pharmaceutical company, Roussel Uclaf, with the participation of the official French network of pharmacovigilance. Under CIOMS auspices, an international meeting was organized to test the feasibility of adapting for international use the outcome of the French consensus meetings on drug-induced liver disorders. The meeting resulted in a series of proposed standard designations of drug-induced liver disorders and criteria of causality assessment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The clinical and biochemical improvement of the patient after stopping the medication, without recurrence, confirms the diagnosis [4-6].”
From Albendazole-induced granulomatous hepatitis: a case report (2013) · cites this paper as [6]
In the citing paper
“This method has proven to be more accurate and reproducible compared with other methods published in the literature [4-6].”
From Albendazole-induced granulomatous hepatitis: a case report (2013) · cites this paper as [6]
In the citing paper
“The most widely used scale is the Council for International Organizations of Medical Sciences (CIOMS)-Roussel Uclaf Causality Assessment Method (RUCAM), developed in 1995, which relates a causative agent and toxic liver damage, and has the following results: “highly probable”, “probable”, “possible”, “unlikely”, or “excluded”, according to the total score.”
From Albendazole-induced granulomatous hepatitis: a case report (2013) · cites this paper as [6]
In the citing paper
“Traditionally, the most widely accepted causality scale for idiosyncratic DILI has been the CIOMS-RUCAM scale [20].”
From DILI Differences and Similarities between the US and Europe (2026) · cites this paper as [20]
In the citing paper
“This updated RUCAM is now in common use and should be applied for future cases replacing earlier versions.12,14”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [14]
Citations
Cites
Consensus meetings on: Causality assessment of drug-induced liver injury
Danan, G. (1988) · Journal of Hepatology · doi:10.1016/s0168-8278(88)80517-8 · Cited by 70
Research works printed but not linked: 9
- Bénichou, 1987, Réunions de consensus sur les définitions en pharmacovigilance, Therapie, 42, 347
- Danan, 1987, Critères d'imputation d'une hépatite aiguë à un médicament. Résultats de réunions de consensus, Gastroenterol Clin Biol, 11, 581
- Solal-Celigny, 1987, Critères d'imputation d'une cytopénie granuleuse ou plaquettaire à un médicament. Résultats de réunions de consensus, Nouv Rev Fr Hematol, 29, 265
- Habibi, 1988, Anémies hémolytiques d'origine médicamenteuse. Résultats de réunions de consensus, Therapie, 43, 117
- Guillaume, 1987, Comment imputer un accident cutané à un médicament. Application aux purpuras vasculaires, Ann Dermatol Venereol, 114, 721
- Roujeau, 1989, Photosensibilité cutanée médicamenteuse. Résultats d'une réunion de consensus, Therapie, 44, 223
- Vigeral, 1989, Les insuffisances rénales d'origine médicamenteuse. Résultats de réunions de consensus, Nephrologie, 10, 157
- Fournier, 1989, Pneumopathies interstitielles. Critères d'imputation à une médicament. Résultats de réuaioas de consensus, Press Msd, 18, 1133
- Bénichou, 1989, Lack of definitions of adverse drug reactions, Drug Inf J, 23, 71
Cited by
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
“Acute drug-induced cholestatic injury represents one of three major forms of drug-induced liver injury (DILI) and has been defined by an international consensus panel by an isolated elevation of serum alkaline phosphatase (AP) >2 ULN or an alanine aminotransferase (ALT)/AP ratio (both elevated above ULN) <2 [178].”
BackgroundAn Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy
Saukkonen, J. J., Cohn, D. L., Jasmer, R. M., Schenker, S., Jereb, J. A., Nolan, C. M., Peloquin, C. A., Gordin, F. M., Nunes, D., Strader, D. B., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1666st · Cited by 912
Case definition and phenotype standardization in drug-induced liver injury
Aithal, G. P., Watkins, P. B., Andrade, R. J., Larrey, D., Molokhia, M., Takikawa, H., Hunt, C. M., Wilke, R. A., Avigan, M., Kaplowitz, N., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.58 · Cited by 944
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Metadata
- Authors
- Benichou, C.
- Corresponding author
- Christian Benichou
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 1990-09
- Volume
- 11
- Issue
- 2
- Pages
- 272-276
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W38847137
- Cited by
- 1,106
- References
- 1
- Citations by year
- 2026: 13 · 2025: 25 · 2024: 29 · 2023: 30 · 2022: 34 · 2021: 39 · 2020: 36 · 2019: 57 · 2018: 47 · 2017: 33 · 2016: 48 · 2015: 40 · 2014: 59 · 2013: 59 · 2012: 44
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- adverse drug reactions, causality assessment, pharmacovigilance, expert consensus, international reporting standards, drug regulatory agencies
- MeSH terms
- France, Humans, International Cooperation, Pilot Projects, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Criteria of drug-induced liver disorders. https://app.cochat.ai/papers/10.1016/0168-8278(90)90124-a
- The paper
- Benichou, C. (1990). Criteria of drug-induced liver disorders. Journal of Hepatology. https://doi.org/10.1016/0168-8278(90)90124-a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.